Adrenal Cortex Carcinoma has active NIH research funding with 8 funded grants totaling $13.7M.
1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Adrenal Cortex Carcinoma. Strongest funded area: Translational / Drug Development. Largest gap: Translational / Drug Development.
3 funded grants in Translational / Drug Development but only 1 related publication found for adrenal cortex carcinoma. This may indicate early-stage research that hasn't yet produced published results.
These grants mention Adrenal Cortex Carcinoma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Adrenal Cortex Carcinoma.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.